Affiliation:
1. Internal Medicine Specialist, Hospital General Ibarra.Ecuador
2. Internal Medicine Specialist, Hospital Básico Antonio Ante. Ecuador
Abstract
If we remember very superficially a little about the complex human immune system, a part of this immune system is made up of leukocytes (especially phagocytes and lymphocytes) that are responsible for detecting invaders and sending them defensive markers that adhere to them (the antibodies) and also to destroy the invaders identified by the system; In addition to the already mentioned leukocytes, our immune system is made up of various other elements such as cells, proteins, tissues and organs, which defend us against germs and microorganisms. 1, 2
Speaking specifically about the immune system and COVID-19, the events mainly involved in the immunopathogenesis of COVID-19 and the dysregulation of the immune response include lymphopenia and increased neutrophil-to-lymphocyte ratio, cytokines, lymphocyte depletion and dysfunction, antibody-dependent enhancement, and monocyte and granulocyte abnormalities. It must be emphasized that lymphopenia is an essential finding in most patients with COVID-19, particularly in those with a severe phenotype.3 It has been shown that multiple viral proteins induce T cells after infection and that T cells that have antiviral signatures related to safety and protection can be achieved by vaccination.4
Subject
Infectious Diseases,Applied Microbiology and Biotechnology,Epidemiology,Biotechnology
Reference17 articles.
1. 1. The history of vaccines [Internet]. The College of Physicians of Philadelphia; 2022 [cited 15 jan 2022]. The Human Immune System and Infectious Disease; [aprox. 5 p.] Available at: https://www.historyofvaccines.org/index.php/content/articles/human-immune-system-and-infectious-disease
2. 2. Palomo I, Pereira J, Koenig C. Células y órganos del sistema inmune. En: Palomo I, Ferreira A, Sepúlveda C, et al. Fundamentos de inmunología básica y clínica. Talca: EDitorial Universidad de Talca; 2002. p. 53-84. Available at: http://editorial.utalca.cl/docs/ebook/inmunologia.pdf
3. 3. Lotfi R, Kalmarzi RN, Roghani SA. A review on the immune responses against novel emerging coronavirus (SARS-CoV-2). Immunol Res. 2021; 69(3), 213–24. DOI: https://doi.org/10.1007/s12026-021-09198-0
4. 4. DiPiazza AT, Graham BS, Ruckwardt TJ. T cell immunity to SARS-CoV-2 following natural infection and vaccination. Biochemical and Biophysical Research Communications. 2021; 538, 211-7. DOI: https://doi.org/10.1016/j.bbrc.2020.10.060.
5. 5. Napoli C, Benincasa G, Criscuolo C, Faenza M, Liberato C, Rusciano M. Immune reactivity during COVID-19: Implications for treatment.